Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy

被引：0
|
作者：
Chi Yan
Ann Richmond
机构：
[1] Tennessee Valley Healthcare System,Department of Pharmacology
[2] Department of Veterans Affairs,undefined
[3] Vanderbilt University School of Medicine,undefined
来源：
Molecular Cancer | / 20卷
关键词：
CD40; Cancer; Nevi; Melanoma; PD-1/PD-L1; CTLA4; Targeted therapy; Immune therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy
    Yan, Chi
    Richmond, Ann
    MOLECULAR CANCER, 2021, 20 (01)
  • [2] A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy
    Yang, Jing
    Zhao, Shilin
    Wang, Jing
    Sheng, Quanhu
    Liu, Qi
    Shyr, Yu
    CANCER RESEARCH, 2022, 82 (04) : 539 - 542
  • [3] Use of CRTAM expression as a predictive biomarker for immune checkpoint blockade in a pan-cancer cohort
    Miyashita, Hirotaka
    Nishizaki, Daisuke
    Lee, Suzanna
    Nesline, Mary K.
    Conroy, Jeffrey M.
    DePietro, Paul
    Pabla, Sarabjot
    Aoshima, Ken
    Kato, Shumei
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Uncovering the Potential of CD40 Agonism to Enhance Immune Checkpoint Blockade
    Wu, Richard C.
    Luke, Jason J.
    CLINICAL CANCER RESEARCH, 2024, 30 (01) : 9 - 11
  • [5] Robust prediction of pan-cancer immune checkpoint blockade response using machine learning
    Chang, Tiangen
    Dhruba, Saugato R.
    Cao, Yingying
    Morris, Luc G.
    Ruppin, Eytan
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
    Huang, Zhiyang
    Li, Yingying
    Zhao, Hong
    Zhao, Bin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [7] A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint
    Zhou, Xiaohan
    Du, Jun
    Liu, Chengdong
    Zeng, Hanyi
    Chen, Yuting
    Liu, Li
    Wu, Dehua
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [8] Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in Cancer
    Rech, Andrew J.
    Dada, Hannah
    Kotzin, Jonathan J.
    Henao-Mejia, Jorge
    Minn, Andy J.
    Victor, Christina Twyman-Saint
    Vonderheide, Robert H.
    CANCER RESEARCH, 2018, 78 (15) : 4282 - 4291
  • [9] A Pan-cancer Analysis of CREBBP as a potential predictor for immune checkpoint therapy.
    Li, Jiaping
    Fan, Wenzhe
    Zhao, Yue
    Xue, Miao
    Chen, Tingting
    Xie, Wenzhuan
    Huang, Mengli
    CANCER RESEARCH, 2021, 81 (13)
  • [10] Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity
    Morrison, Alexander H.
    Diamond, Mark S.
    Hay, Ceire A.
    Byrne, Katelyn T.
    Vonderheide, Robert H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (14) : 8022 - 8031
12345